These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
432 related articles for article (PubMed ID: 16640452)
1. Hypericum perforatum: a 'modern' herbal antidepressant: pharmacokinetics of active ingredients. Wurglics M; Schubert-Zsilavecz M Clin Pharmacokinet; 2006; 45(5):449-68. PubMed ID: 16640452 [TBL] [Abstract][Full Text] [Related]
2. Investigation of pharmacokinetic data of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin revealed from single and multiple oral dose studies with a hypericum extract containing tablet in healthy male volunteers. Schulz HU; Schürer M; Bässler D; Weiser D Arzneimittelforschung; 2005; 55(10):561-8. PubMed ID: 16294501 [TBL] [Abstract][Full Text] [Related]
3. Step by step removal of hyperforin and hypericin: activity profile of different Hypericum preparations in behavioral models. Butterweck V; Christoffel V; Nahrstedt A; Petereit F; Spengler B; Winterhoff H Life Sci; 2003 Jun; 73(5):627-39. PubMed ID: 12770617 [TBL] [Abstract][Full Text] [Related]
4. Investigation of the bioavailability of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin following single and multiple oral dosing of a hypericum extract containing tablet. Schulz HU; Schürer M; Bässler D; Weiser D Arzneimittelforschung; 2005; 55(1):15-22. PubMed ID: 15727160 [TBL] [Abstract][Full Text] [Related]
5. St. John's wort: role of active compounds for its mechanism of action and efficacy. Butterweck V; Schmidt M Wien Med Wochenschr; 2007; 157(13-14):356-61. PubMed ID: 17704987 [TBL] [Abstract][Full Text] [Related]
6. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect]. Vacek J; Klejdus B; Kubán V Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of the antidepressant St. John's wort (hypericum perforatum) on rat bladder contractility in vitro. Capasso R; Borrelli F; Capasso F; Mascolo N; Izzo AA Urology; 2004 Jul; 64(1):168-72. PubMed ID: 15245964 [TBL] [Abstract][Full Text] [Related]
8. In vitro photochemical and phototoxicological characterization of major constituents in St. John's Wort (Hypericum perforatum) extracts. Onoue S; Seto Y; Ochi M; Inoue R; Ito H; Hatano T; Yamada S Phytochemistry; 2011 Oct; 72(14-15):1814-20. PubMed ID: 21782201 [TBL] [Abstract][Full Text] [Related]
9. In vitro binding studies with two hypericum perforatum extracts--hyperforin, hypericin and biapigenin--on 5-HT6, 5-HT7, GABA(A)/benzodiazepine, sigma, NPY-Y1/Y2 receptors and dopamine transporters. Gobbi M; Moia M; Pirona L; Morizzoni P; Mennini T Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S45-8. PubMed ID: 11518075 [TBL] [Abstract][Full Text] [Related]
10. Effects of the antidepressant St. John's wort (Hypericum perforatum) on rat and human vas deferens contractility. Capasso R; Borrelli F; Montanaro V; Altieri V; Capasso F; Izzo AA J Urol; 2005 Jun; 173(6):2194-7. PubMed ID: 15879886 [TBL] [Abstract][Full Text] [Related]
11. [Cellular and molecular effects of the antidepressant hyperforin on brain cells: Review of the literature]. Bouron A; Lorrain E Encephale; 2014 Apr; 40(2):108-13. PubMed ID: 23816060 [TBL] [Abstract][Full Text] [Related]
12. The antidepressant mechanism of Hypericum perforatum. Mennini T; Gobbi M Life Sci; 2004 Jul; 75(9):1021-7. PubMed ID: 15207650 [TBL] [Abstract][Full Text] [Related]
13. Role of hyperforin in the pharmacological activities of St. John's Wort. Zanoli P CNS Drug Rev; 2004; 10(3):203-18. PubMed ID: 15492771 [TBL] [Abstract][Full Text] [Related]
14. A mechanistic study on altered pharmacokinetics of irinotecan by St. John's wort. Hu ZP; Yang XX; Chen X; Cao J; Chan E; Duan W; Huang M; Yu XQ; Wen JY; Zhou SF Curr Drug Metab; 2007 Feb; 8(2):157-71. PubMed ID: 17305494 [TBL] [Abstract][Full Text] [Related]
15. Hypericum perforatum (St John's wort) beyond depression: A therapeutic perspective for pain conditions. Galeotti N J Ethnopharmacol; 2017 Mar; 200():136-146. PubMed ID: 28216196 [TBL] [Abstract][Full Text] [Related]
16. The main components of St John's Wort inhibit low-density lipoprotein atherogenic modification: a beneficial "side effect" of an OTC antidepressant drug? Laggner H; Schreier S; Hermann M; Exner M; Mühl A; Gmeiner BM; Kapiotis S Free Radic Res; 2007 Feb; 41(2):234-41. PubMed ID: 17364950 [TBL] [Abstract][Full Text] [Related]
17. Antidepressant activity of hyperforin conjugates of the St. John's wort, Hypericum perforatum Linn.: an experimental study. Muruganandam AV; Bhattacharya SK; Ghosal S Indian J Exp Biol; 2001 Dec; 39(12):1302-4. PubMed ID: 12018529 [TBL] [Abstract][Full Text] [Related]
18. Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions. Russo E; Scicchitano F; Whalley BJ; Mazzitello C; Ciriaco M; Esposito S; Patanè M; Upton R; Pugliese M; Chimirri S; Mammì M; Palleria C; De Sarro G Phytother Res; 2014 May; 28(5):643-55. PubMed ID: 23897801 [TBL] [Abstract][Full Text] [Related]
19. St. John's wort components and the brain: uptake, concentrations reached and the mechanisms underlying pharmacological effects. Caccia S; Gobbi M Curr Drug Metab; 2009 Nov; 10(9):1055-65. PubMed ID: 20214594 [TBL] [Abstract][Full Text] [Related]
20. Do other Hypericum species have medical potential as St. John's wort (Hypericum perforatum)? Stojanović G; Ðorđević A; Šmelcerović A Curr Med Chem; 2013; 20(18):2273-95. PubMed ID: 23521674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]